55 research outputs found

    Pushing the Limits: Cognitive, Affective, and Neural Plasticity Revealed by an Intensive Multifaceted Intervention.

    Get PDF
    Scientific understanding of how much the adult brain can be shaped by experience requires examination of how multiple influences combine to elicit cognitive, affective, and neural plasticity. Using an intensive multifaceted intervention, we discovered that substantial and enduring improvements can occur in parallel across multiple cognitive and neuroimaging measures in healthy young adults. The intervention elicited substantial improvements in physical health, working memory, standardized test performance, mood, self-esteem, self-efficacy, mindfulness, and life satisfaction. Improvements in mindfulness were associated with increased degree centrality of the insula, greater functional connectivity between insula and somatosensory cortex, and reduced functional connectivity between posterior cingulate cortex (PCC) and somatosensory cortex. Improvements in working memory and reading comprehension were associated with increased degree centrality of a region within the middle temporal gyrus (MTG) that was extensively and predominately integrated with the executive control network. The scope and magnitude of the observed improvements represent the most extensive demonstration to date of the considerable human capacity for change. These findings point to higher limits for rapid and concurrent cognitive, affective, and neural plasticity than is widely assumed

    Insulation for Daydreams: A Role for Tonic Norepinephrine in the Facilitation of Internally Guided Thought

    Get PDF
    Although consciousness can be brought to bear on both perceptual and internally generated information, little is known about how these different cognitive modes are coordinated. Here we show that between-participant variance in thoughts unrelated to the task being performed (known as task unrelated thought, TUT) is associated with longer response times (RT) when target presentation occurs during periods when baseline Pupil Diameter (PD) is increased. As behavioral interference due to high baseline PD can reflect increased tonic activity in the norepinephrine system (NE), these results might implicate high tonic NE activity in the facilitation of TUTs. Based on these findings, it is hypothesised that high tonic mode NE leads to a generalised de-amplification of task relevant information that prioritses internally generated thought and insulates it from the potentially disruptive events taking place in the external environment

    Assessing the near threshold cross section of the O 17 ( n , α ) C 14 reaction by means of the Trojan horse method

    Get PDF
    The study of the ^{17}\mathrm{O}(n,\ensuremath{\alpha})^{14}\mathrm{C} reaction has been performed by means of the Trojan horse method (THM) applied to the quasifree ^{2}\mathrm{H}(^{17}\mathrm{O},\ensuremath{\alpha}^{14}\mathrm{C})^{1}\mathrm{H} reaction induced at a beam energy of 43.5 MeV. The THM allowed us to study the 8121-keV 18O∗^{18}\mathrm{O}^{*} resonant level, for which the previous THM investigation pointed out the ability of the method to overcome the centrifugal barrier suppression effects in the entrance channel. Here, in view of the developments of the method for resonant reactions, the detailed analysis of the performed experiment will be discussed, focusing on the extraction of the 8121-keV resonance strength for which no information is present in scientific literature. Moreover, the experimental results clearly show the excitation of the subthreshold level centered at \ensuremath{-}6 keV in the center-of-mass system, which is fundamental to determine the ^{17}\mathrm{O}(n,\ensuremath{\alpha})^{14}\mathrm{C} reaction rate of astrophysical interest. Finally, a new recommended reaction rate is presented for future astrophysical application

    Improvement of the high-accuracy O 17 ( p , α ) N 14 reaction-rate measurement via the Trojan Horse method for application to O 17 nucleosynthesis

    Get PDF
    The ^{17}\text{O}(p,\ensuremath{\alpha})^{14}\text{N} and ^{17}\text{O}(p,\ensuremath{\gamma})^{18}\text{F} reactions are of paramount importance for the nucleosynthesis in a number of stellar sites, including red giants (RGs), asymptotic giant branch (AGB) stars, massive stars, and classical novae. In particular, they govern the destruction of 17O^{17}\text{O} and the formation of the short-lived radioisotope 18F^{18}\text{F}, which is of special interest for \ensuremath{\gamma}-ray astronomy. At temperatures typical of the above-mentioned astrophysical scenario, T=0.01T=0.01--0.1 GK for RG, AGB, and massive stars and T=0.1T=0.1--0.4 GK for a classical nova explosion, the ^{17}\text{O}(p,\ensuremath{\alpha})^{14}\text{N} reaction cross section is dominated by two resonances: one at about ERcm=65{E}_{R}^{cm}=65 keV above the 18F^{18}\text{F} proton threshold energy, corresponding to the EX=5.673{E}_{X}=5.673 MeV level in 18F^{18}\text{F}, and another one at ERcm=183{E}_{R}^{cm}=183 keV (EX=5.786({E}_{X}=5.786 MeV). We report on the indirect study of the ^{17}\text{O}(p,\ensuremath{\alpha})^{14}\text{N} reaction via the Trojan Horse method by applying the approach recently developed for extracting the strength of narrow resonance at ultralow energies. The mean value of the strengths obtained in the two measurements was calculated and compared with the direct data available in literature. This value was used as input parameter for reaction-rate determination and its comparison with the result of the direct measurement is also discussed in the light of the electron screening effect

    Towards the clinical implementation of pharmacogenetics in bipolar disorder.

    Get PDF
    BackgroundBipolar disorder (BD) is a psychiatric illness defined by pathological alterations between the mood states of mania and depression, causing disability, imposing healthcare costs and elevating the risk of suicide. Although effective treatments for BD exist, variability in outcomes leads to a large number of treatment failures, typically followed by a trial and error process of medication switches that can take years. Pharmacogenetic testing (PGT), by tailoring drug choice to an individual, may personalize and expedite treatment so as to identify more rapidly medications well suited to individual BD patients.DiscussionA number of associations have been made in BD between medication response phenotypes and specific genetic markers. However, to date clinical adoption of PGT has been limited, often citing questions that must be answered before it can be widely utilized. These include: What are the requirements of supporting evidence? How large is a clinically relevant effect? What degree of specificity and sensitivity are required? Does a given marker influence decision making and have clinical utility? In many cases, the answers to these questions remain unknown, and ultimately, the question of whether PGT is valid and useful must be determined empirically. Towards this aim, we have reviewed the literature and selected drug-genotype associations with the strongest evidence for utility in BD.SummaryBased upon these findings, we propose a preliminary panel for use in PGT, and a method by which the results of a PGT panel can be integrated for clinical interpretation. Finally, we argue that based on the sufficiency of accumulated evidence, PGT implementation studies are now warranted. We propose and discuss the design for a randomized clinical trial to test the use of PGT in the treatment of BD

    Towards the clinical implementation of pharmacogenetics in bipolar disorder

    Full text link
    • …
    corecore